Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 06-Mar-24 4:46 PM View:  | Moran Kevin Patrick SVP, CFO & Treasurer | Vanda Pharmaceuticals, Inc. (VNDA) | 05-Mar-24 | Sale | 8,902 | $4.20 | $37,410.70 | (4%) 240.55K to 231.65K | |
| 06-Mar-24 4:46 PM View: | Birznieks Gunther SVP, Business Development | Vanda Pharmaceuticals, Inc. (VNDA) | 05-Mar-24 | Sale | 8,684 | $4.13 | $35,884.00 | (3%) 322.25K to 313.57K | |
| 06-Mar-24 4:48 PM View: | Wijkstrom Joakim SVP, Chief Marketing Officer | Vanda Pharmaceuticals, Inc. (VNDA) | 05-Mar-24 | Sale | 9,229 | $4.21 | $38,830.10 | (7%) 139.02K to 129.79K | |
| 06-Mar-24 4:47 PM View: | Polymeropoulos Mihael Hristos President and CEO Director | Vanda Pharmaceuticals, Inc. (VNDA) | 05-Mar-24 | Sale | 24,288 | $4.13 | $100,273.00 | (1%) 1.9M to 1.87M | |
| 06-Mar-24 4:50 PM View: | Williams Timothy SVP & General Counsel | Vanda Pharmaceuticals, Inc. (VNDA) | 05-Mar-24 | Sale | 8,941 | $4.18 | $37,395.70 | (4%) 205.77K to 196.82K | |
| 06-Mar-24 4:47 PM View: | Polymeropoulos Mihael Hristos President and CEO Director | Vanda Pharmaceuticals, Inc. (VNDA) | 04-Mar-24 | Sale | 30,884 | $4.24 | $131,066.00 | (2%) 1.93M to 1.9M | |
| 06-Mar-24 4:50 PM View: | Williams Timothy SVP & General Counsel | Vanda Pharmaceuticals, Inc. (VNDA) | 04-Mar-24 | Sale | 8,147 | $4.41 | $35,916.90 | (4%) 213.91K to 205.77K | |
| 06-Mar-24 4:46 PM View: | Moran Kevin Patrick SVP, CFO & Treasurer | Vanda Pharmaceuticals, Inc. (VNDA) | 04-Mar-24 | Sale | 5,798 | $4.48 | $25,982.00 | (2%) 246.35K to 240.55K | |
| 06-Mar-24 4:46 PM View: | Birznieks Gunther SVP, Business Development | Vanda Pharmaceuticals, Inc. (VNDA) | 04-Mar-24 | Sale | 8,727 | $4.30 | $37,494.70 | (3%) 330.98K to 322.25K | |
| 06-Mar-24 4:48 PM View: | Wijkstrom Joakim SVP, Chief Marketing Officer | Vanda Pharmaceuticals, Inc. (VNDA) | 04-Mar-24 | Sale | 7,498 | $4.41 | $33,090.90 | (5%) 146.52K to 139.02K | |
| 21-Feb-24 4:53 PM View: | Williams Timothy SVP & General Counsel | Vanda Pharmaceuticals, Inc. (VNDA) | 16-Feb-24 | Grant | 125,000 | -- | -- | 141% 88.91K to 213.91K | |
| 21-Feb-24 4:52 PM View: | Moran Kevin Patrick SVP, CFO & Treasurer | Vanda Pharmaceuticals, Inc. (VNDA) | 16-Feb-24 | Grant | 125,000 | -- | -- | 103% 121.35K to 246.35K | |
| 21-Feb-24 4:50 PM View: | Birznieks Gunther SVP, Business Development | Vanda Pharmaceuticals, Inc. (VNDA) | 16-Feb-24 | Grant | 125,000 | -- | -- | 61% 205.98K to 330.98K | |
| 21-Feb-24 4:52 PM View: | Wijkstrom Joakim SVP, Chief Marketing Officer | Vanda Pharmaceuticals, Inc. (VNDA) | 16-Feb-24 | Grant | 32,700 | -- | -- | 29% 113.82K to 146.52K | |
| 21-Feb-24 4:52 PM View: | Polymeropoulos Mihael Hristos President and CEO Director | Vanda Pharmaceuticals, Inc. (VNDA) | 16-Feb-24 | Grant | 450,000 | -- | -- | 30% 1.48M to 1.93M | |
| 23-Aug-23 4:23 PM View: | Wijkstrom Joakim SVP, Chief Marketing Officer | Vanda Pharmaceuticals, Inc. (VNDA) | 21-Aug-23 | Sale | 3,724 | $5.84 | $21,748.20 | (3%) 117.54K to 113.82K | |
| 11-Aug-23 4:36 PM View: | Mitchell Stephen Ray Director | Vanda Pharmaceuticals, Inc. (VNDA) | 10-Aug-23 | Sale | 6,500 | $6.05 | $39,349.10 | (18%) 35.83K to 29.33K | |
| 01-Aug-23 4:30 PM View: | Moran Kevin Patrick SVP, CFO & Treasurer | Vanda Pharmaceuticals, Inc. (VNDA) | 28-Jul-23 | Sale | 2,212 | $6.30 | $13,944.60 | (2%) 123.56K to 121.35K | |
| 20-Jun-23 4:34 PM View: | Moran Kevin Patrick SVP, CFO & Treasurer | Vanda Pharmaceuticals, Inc. (VNDA) | 15-Jun-23 | Sale | 16,000 | $6.29 | $100,710.00 | (11%) 139.56K to 123.56K | |
| 15-Jun-23 4:20 PM View: | Williams Timothy SVP & General Counsel | Vanda Pharmaceuticals, Inc. (VNDA) | 13-Jun-23 | Sale | 14,600 | $6.56 | $95,754.10 | (14%) 103.51K to 88.91K | |
| 12-Jun-23 4:18 PM View: | Dugan Richard W Director | Vanda Pharmaceuticals, Inc. (VNDA) | 08-Jun-23 | Grant | 17,307 | -- | -- | 22% 80.39K to 97.7K | |
| 12-Jun-23 4:19 PM View: | Mitchell Stephen Ray Director | Vanda Pharmaceuticals, Inc. (VNDA) | 08-Jun-23 | Grant | 17,307 | -- | -- | 93% 18.52K to 35.83K | |
| 12-Jun-23 4:19 PM View: | Honore Tage Director | Vanda Pharmaceuticals, Inc. (VNDA) | 08-Jun-23 | Grant | 17,307 | -- | -- | 66% 26.41K to 43.72K | |
| 12-Jun-23 4:17 PM View: | Chrousos Phaedra Director | Vanda Pharmaceuticals, Inc. (VNDA) | 08-Jun-23 | Grant | 17,307 | -- | -- | 69% 24.93K to 42.24K | |
| 12-Jun-23 4:20 PM View: | Ward Anne Sempowski Director | Vanda Pharmaceuticals, Inc. (VNDA) | 08-Jun-23 | Grant | 17,307 | -- | -- | 79% 22.01K to 39.31K | |
| 17-Mar-23 4:50 PM View: | Honore Tage Director | Vanda Pharmaceuticals, Inc. (VNDA) | 15-Mar-23 | Grant | 26,408 | -- | -- | 100% 0 to 26.41K | |
| 06-Mar-23 6:24 PM View: | Birznieks Gunther SVP, Business Development | Vanda Pharmaceuticals, Inc. (VNDA) | 03-Mar-23 | Sale | 8,268 | $6.26 | $51,790.80 | (4%) 214.25K to 205.98K | |
| 06-Mar-23 6:26 PM View: | Williams Timothy SVP & General Counsel | Vanda Pharmaceuticals, Inc. (VNDA) | 03-Mar-23 | Sale | 8,301 | $6.25 | $51,887.10 | (7%) 111.81K to 103.51K | |
| 06-Mar-23 6:25 PM View: | Moran Kevin Patrick SVP, CFO & Treasurer | Vanda Pharmaceuticals, Inc. (VNDA) | 03-Mar-23 | Sale | 5,968 | $6.28 | $37,498.70 | (4%) 145.53K to 139.56K | |
| 06-Mar-23 6:25 PM View: | Polymeropoulos Mihael Hristos President and CEO Director | Vanda Pharmaceuticals, Inc. (VNDA) | 03-Mar-23 | Sale | 22,538 | $6.25 | $140,876.00 | (2%) 1.5M to 1.48M | |
| 06-Mar-23 6:26 PM View: | Wijkstrom Joakim SVP, Chief Marketing Officer | Vanda Pharmaceuticals, Inc. (VNDA) | 03-Mar-23 | Sale | 4,113 | $6.32 | $25,994.20 | (3%) 121.65K to 117.54K | |
| 06-Mar-23 6:26 PM View: | Williams Timothy SVP & General Counsel | Vanda Pharmaceuticals, Inc. (VNDA) | 02-Mar-23 | Sale | 8,437 | $6.24 | $52,684.80 | (7%) 120.25K to 111.81K | |
| 06-Mar-23 6:25 PM View: | Moran Kevin Patrick SVP, CFO & Treasurer | Vanda Pharmaceuticals, Inc. (VNDA) | 02-Mar-23 | Sale | 7,966 | $6.26 | $49,845.70 | (5%) 153.5K to 145.53K | |
| 06-Mar-23 6:25 PM View: | Polymeropoulos Mihael Hristos President and CEO Director | Vanda Pharmaceuticals, Inc. (VNDA) | 02-Mar-23 | Sale | 22,426 | $6.23 | $139,718.00 | (1%) 1.52M to 1.5M | |
| 06-Mar-23 6:26 PM View: | Wijkstrom Joakim SVP, Chief Marketing Officer | Vanda Pharmaceuticals, Inc. (VNDA) | 02-Mar-23 | Sale | 7,720 | $6.23 | $48,122.60 | (6%) 129.37K to 121.65K | |
| 06-Mar-23 6:24 PM View: | Birznieks Gunther SVP, Business Development | Vanda Pharmaceuticals, Inc. (VNDA) | 02-Mar-23 | Sale | 8,509 | $6.20 | $52,793.20 | (4%) 222.76K to 214.25K | |
| 21-Feb-23 6:11 PM View: | Williams Timothy SVP & General Counsel | Vanda Pharmaceuticals, Inc. (VNDA) | 16-Feb-23 | Grant | 32,700 | -- | -- | 37% 87.55K to 120.25K | |
| 21-Feb-23 6:08 PM View: | Birznieks Gunther SVP, Business Development | Vanda Pharmaceuticals, Inc. (VNDA) | 16-Feb-23 | Grant | 32,700 | -- | -- | 17% 190.06K to 222.76K | |
| 21-Feb-23 6:10 PM View: | Polymeropoulos Mihael Hristos President and CEO Director | Vanda Pharmaceuticals, Inc. (VNDA) | 16-Feb-23 | Grant | 115,000 | -- | -- | 8% 1.41M to 1.52M | |
| 21-Feb-23 6:09 PM View: | Moran Kevin Patrick SVP, CFO & Treasurer | Vanda Pharmaceuticals, Inc. (VNDA) | 16-Feb-23 | Grant | 32,700 | -- | -- | 27% 120.8K to 153.5K | |
| 21-Feb-23 6:11 PM View: | Wijkstrom Joakim SVP, Chief Marketing Officer | Vanda Pharmaceuticals, Inc. (VNDA) | 16-Feb-23 | Grant | 32,700 | -- | -- | 34% 96.67K to 129.37K | |
| 16-Dec-22 4:38 PM View: | Williams Timothy SVP & General Counsel | Vanda Pharmaceuticals, Inc. (VNDA) | 15-Dec-22 | Sale | 8,000 | $7.01 | $56,069.60 | (8%) 95.55K to 87.55K | |
| 07-Dec-22 5:56 PM View: | Moran Kevin Patrick SVP, CFO & Treasurer | Vanda Pharmaceuticals, Inc. (VNDA) | 06-Dec-22 | Option Exercise | 7,500 | $3.12 | $23,400.00 | 6% 118.09K to 125.59K | |
| 07-Dec-22 5:58 PM View: | Polymeropoulos Mihael Hristos President and CEO Director | Vanda Pharmaceuticals, Inc. (VNDA) | 06-Dec-22 | Option Exercise | 75,365 | $3.12 | $235,139.00 | 5% 1.38M to 1.46M | |
| 07-Dec-22 5:56 PM View: | Moran Kevin Patrick SVP, CFO & Treasurer | Vanda Pharmaceuticals, Inc. (VNDA) | 06-Dec-22 | Option Sale | 4,792 | $10.61 | $50,826.80 | (4%) 125.59K to 120.8K | |
| 07-Dec-22 5:58 PM View: | Polymeropoulos Mihael Hristos President and CEO Director | Vanda Pharmaceuticals, Inc. (VNDA) | 06-Dec-22 | Option Sale | 48,250 | $10.61 | $512,082.00 | (3%) 1.46M to 1.41M | |
| 07-Dec-22 5:58 PM View: | Polymeropoulos Mihael Hristos President and CEO Director | Vanda Pharmaceuticals, Inc. (VNDA) | 05-Dec-22 | Option Sale | 47,650 | $10.62 | $506,200.00 | (3%) 1.43M to 1.38M | |
| 07-Dec-22 5:58 PM View: | Polymeropoulos Mihael Hristos President and CEO Director | Vanda Pharmaceuticals, Inc. (VNDA) | 05-Dec-22 | Option Exercise | 74,635 | $3.12 | $232,861.00 | 6% 1.35M to 1.43M | |
| 29-Aug-22 5:02 PM View: | Birznieks Gunther SVP, Business Development | Vanda Pharmaceuticals, Inc. (VNDA) | 26-Aug-22 | Option Exercise | 1,250 | $3.12 | $3,900.00 | < 1% 188.81K to 190.06K | |
| 23-Aug-22 5:01 PM View: | Wijkstrom Joakim SVP, Chief Marketing Officer | Vanda Pharmaceuticals, Inc. (VNDA) | 22-Aug-22 | Sale | 3,605 | $10.27 | $37,007.50 | (4%) 100.28K to 96.67K |
